Search Results - "Morand EF"

This result is not displayed to guests.
Login for full access.

Methotrexate use in systemic lupus erythematosus.

Authors: Kipen, Y. Littlejohn, GO Morand, EF

Source: Lupus. 1997, Vol. 6 Issue 4, p385-389. 5p.

Association of serum B cell activating factor from the tumour necrosis factor family (BAFF) and a proliferation-inducing ligand (APRIL) with central nervous system and renal disease in systemic lupus erythematosus.

Authors: Vincent, FB Northcott, M Hoi, A et al.

Source: Lupus. Aug2013, Vol. 22 Issue 9, p873-884. 12p. 1 Chart, 5 Graphs.

Lymphocytes from systemic lupus erythematosus patients display increased spreading on VCAM-1, an effect associated with active renal involvement.

Authors: Cheng, Q Hoi, A Hickey, MJ et al.

Source: Lupus. Jun2012, Vol. 21 Issue 6, p632-641. 10p. 1 Chart, 4 Graphs.

Reperfusion-induced myocardial dysfunction is prevented by endogenous annexin-A1 and its N-terminal-derived peptide Ac-ANX-A1(2-26).

Authors: Qin C Buxton KD Pepe S et al.

Source: British Journal of Pharmacology. Jan2013, Vol. 168 Issue 1, p238-252. 15p.

Endogenous estrogen regulation of inflammatory arthritis and cytokine expression in male mice, predominantly via estrogen receptor alpha.

Authors: Yang YH Ngo D Jones M et al.

Source: Arthritis & Rheumatism. Apr2010, Vol. 62 Issue 4, p1017-1025. 9p.

Reduction of arthritis severity in protease-activated receptor-deficient mice.

Authors: Yang YH Hall P Little CB et al.

Source: Arthritis & Rheumatism. Apr2005, Vol. 52 Issue 4, p1325-1332. 8p.

Efficacy and safety of enpatoran, a Toll-like receptor 7/8 inhibitor, in patients with skin manifestations of cutaneous lupus erythematosus or systemic lupus erythematosus: findings from Cohort A of a multicentre, international, double-blind, placebo-controlled, dose-finding phase 2 trial.

Authors: Morand EF Werth VP Wenzel J et al.

Source: The Lancet. Rheumatology [Lancet Rheumatol] 2026 Jul; Vol. 8 (7), pp. e513-e527. Date of Electronic Publication: 2026 May 07.

Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Clinical Trial, Phase II

Journal Info: Publisher: Elsevier Ltd Country of Publication: England NLM ID: 101765308 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2665-9913 (Electronic) Linking ISSN: 26659913 NLM ISO Abbreviation: Lancet Rheumatol Subsets: MEDLINE

Efficacy and safety of the CD40 ligand inhibitor dapirolizumab pegol in systemic lupus erythematosus (PHOENYCS GO): a randomised, double-blind, placebo-controlled, phase 3 trial.

Authors: Clowse MEB Isenberg DA Merrill JT et al.

Corporate Authors: Clowse MEB Isenberg DA Merrill JT et al.

Source: Lancet (London, England) [Lancet] 2026 Jun 06; Vol. 407 (10545), pp. 2291-2304. Date of Electronic Publication: 2026 May 29.

Publication Type: Journal Article; Randomized Controlled Trial; Clinical Trial, Phase III; Multicenter Study

Journal Info: Publisher: Elsevier Country of Publication: England NLM ID: 2985213R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1474-547X (Electronic) Linking ISSN: 01406736 NLM ISO Abbreviation: Lancet Subsets: MEDLINE

Efficacy and Safety of Subcutaneous Anifrolumab in Systemic Lupus Erythematosus: A Randomized, Phase 3 Study.

Authors: Manzi S Bruce IN Morand EF et al.

Corporate Authors: Manzi S Bruce IN Morand EF et al.

Source: Arthritis & rheumatology (Hoboken, N.J.) [Arthritis Rheumatol] 2026 Jun; Vol. 78 (6), pp. 1258-1267. Date of Electronic Publication: 2026 Feb 17.

Publication Type: Journal Article; Randomized Controlled Trial; Clinical Trial, Phase III; Multicenter Study

Journal Info: Publisher: Wiley Country of Publication: United States NLM ID: 101623795 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2326-5205 (Electronic) Linking ISSN: 23265191 NLM ISO Abbreviation: Arthritis Rheumatol Subsets: MEDLINE

Can disease activity and treatment responses be captured by a core set of domains in SLE clinical trials? An analysis of phase III belimumab trial data.

Authors: Lin A Kandane-Rathnayake R Morand EF et al.

Source: Lupus science & medicine [Lupus Sci Med] 2026 May 21; Vol. 13 (1). Date of Electronic Publication: 2026 May 21.

Publication Type: Journal Article; Clinical Trial, Phase III; Randomized Controlled Trial

Journal Info: Publisher: BMJ Country of Publication: England NLM ID: 101633705 Publication Model: Electronic Cited Medium: Print ISSN: 2053-8790 (Print) Linking ISSN: 20538790 NLM ISO Abbreviation: Lupus Sci Med Subsets: MEDLINE

Enpatoran, a Toll-like receptor 7/8 inhibitor, in moderate-to-severe systemic lupus erythematosus: findings from Cohort B of a multicentre, international, double-blind, placebo-controlled dose-finding phase 2 trial.

Authors: Morand EF Dall'Era M Sanchez-Guerrero J et al.

Source: Lancet (London, England) [Lancet] 2026 May 09; Vol. 407 (10541), pp. 1809-1824.

Publication Type: Journal Article; Clinical Trial, Phase II; Randomized Controlled Trial; Multicenter Study

Journal Info: Publisher: Elsevier Country of Publication: England NLM ID: 2985213R Publication Model: Print Cited Medium: Internet ISSN: 1474-547X (Electronic) Linking ISSN: 01406736 NLM ISO Abbreviation: Lancet Subsets: MEDLINE

Association of lupus low disease activity state and remission with reduced organ damage and flare in systemic lupus erythematosus patients with high disease activity: a multi-national, longitudinal cohort study.

Authors: Kandane-Rathnayake R Golder V Louthrenoo W et al.

Source: Rheumatology (Oxford, England) [Rheumatology (Oxford)] 2025 May 01; Vol. 64 (5), pp. 2741-2748.

Publication Type: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Oxford University Press Country of Publication: England NLM ID: 100883501 Publication Model: Print Cited Medium: Internet ISSN: 1462-0332 (Electronic) Linking ISSN: 14620324 NLM ISO Abbreviation: Rheumatology (Oxford) Subsets: MEDLINE

Discordance Between Systemic Lupus Erythematosus Disease Activity Index Domain Weights and Their Association With Organ Damage Accrual.

Authors: Zhang K Morand EF Boyd SE et al.

Source: Arthritis care & research [Arthritis Care Res (Hoboken)] 2026 Apr 28. Date of Electronic Publication: 2026 Apr 28.

Publication Type: Journal Article

Journal Info: Publisher: John Wiley & Sons Country of Publication: United States NLM ID: 101518086 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2151-4658 (Electronic) Linking ISSN: 2151464X NLM ISO Abbreviation: Arthritis Care Res (Hoboken) Subsets: MEDLINE

Demographic and clinical characteristics of patients with systemic lupus erythematosus across five registries: the LupusNet federated data network.

Authors: Zazzetti F Orillion A Sbarigia U et al.

Source: Lupus science & medicine [Lupus Sci Med] 2026 Apr 10; Vol. 13 (1). Date of Electronic Publication: 2026 Apr 10.

Publication Type: Journal Article

Journal Info: Publisher: BMJ Country of Publication: England NLM ID: 101633705 Publication Model: Electronic Cited Medium: Print ISSN: 2053-8790 (Print) Linking ISSN: 20538790 NLM ISO Abbreviation: Lupus Sci Med Subsets: MEDLINE

Efficacy and safety of anifrolumab in patients with systemic lupus erythematosus without prior immunosuppressant use: post hoc analysis of phase 3 TULIP-1 and TULIP-2 trials.

Authors: Doria A van Vollenhoven RF Morand EF et al.

Source: Lupus science & medicine [Lupus Sci Med] 2026 Apr 08; Vol. 13 (1). Date of Electronic Publication: 2026 Apr 08.

Publication Type: Journal Article; Clinical Trial, Phase III; Randomized Controlled Trial

Journal Info: Publisher: BMJ Country of Publication: England NLM ID: 101633705 Publication Model: Electronic Cited Medium: Print ISSN: 2053-8790 (Print) Linking ISSN: 20538790 NLM ISO Abbreviation: Lupus Sci Med Subsets: MEDLINE

Predictors of damage accrual by organ domain in systemic lupus erythematosus.

Authors: Kandane-Rathnayake R Zolio L Choi JI et al.

Source: Rheumatology (Oxford, England) [Rheumatology (Oxford)] 2026 Feb 04; Vol. 65 (2).

Publication Type: Journal Article

Journal Info: Publisher: Oxford University Press Country of Publication: England NLM ID: 100883501 Publication Model: Print Cited Medium: Internet ISSN: 1462-0332 (Electronic) Linking ISSN: 14620324 NLM ISO Abbreviation: Rheumatology (Oxford) Subsets: MEDLINE; In Process

Disease progression in patients with systemic lupus erythematosus: an analysis of the SLE Prospective Observational Cohort Study (SPOCS).

Authors: Morand EF Furie R Aringer M et al.

Source: Rheumatology (Oxford, England) [Rheumatology (Oxford)] 2026 Feb 04; Vol. 65 (2).

Publication Type: Journal Article; Observational Study

Journal Info: Publisher: Oxford University Press Country of Publication: England NLM ID: 100883501 Publication Model: Print Cited Medium: Internet ISSN: 1462-0332 (Electronic) Linking ISSN: 14620324 NLM ISO Abbreviation: Rheumatology (Oxford) Subsets: MEDLINE

Disease activity and glucocorticoid tapering patterns in Japanese patients with systemic lupus erythematosus treated with anifrolumab: Post hoc analysis of the Japanese subpopulation of the TULIP-2 study.

Authors: Tanaka Y Atsumi T Okada M et al.

Source: Modern rheumatology [Mod Rheumatol] 2025 Apr 08; Vol. 35 (3), pp. 470-477.

Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial

Journal Info: Publisher: Oxford University Press Country of Publication: England NLM ID: 100959226 Publication Model: Print Cited Medium: Internet ISSN: 1439-7609 (Electronic) Linking ISSN: 14397595 NLM ISO Abbreviation: Mod Rheumatol Subsets: MEDLINE

The implication of anti-Ro60 with or without anti-Ro52 antibody in patients with systemic lupus erythematosus.

Authors: Liao K Li N Bonin J et al.

Source: Rheumatology (Oxford, England) [Rheumatology (Oxford)] 2025 Apr 01; Vol. 64 (4), pp. 1923-1929.

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Oxford University Press Country of Publication: England NLM ID: 100883501 Publication Model: Print Cited Medium: Internet ISSN: 1462-0332 (Electronic) Linking ISSN: 14620324 NLM ISO Abbreviation: Rheumatology (Oxford) Subsets: MEDLINE